FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

435911000001105: Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16618701000001112 Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
37771501000001113 Magnapen 250mg/250mg capsules (Wockhardt UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) Is a Product containing precisely ampicillin 250 milligram and flucloxacillin 250 milligram/1 each conventional release oral capsule false Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) Is a Co-fluampicil 250mg/250mg capsules true Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) Is a Co-fluampicil 250mg/250mg capsules false Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) Has active ingredient Bactericide false Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) Has active ingredient Ampicillin trihydrate false Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) Has active ingredient Ampicillin false Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) Has active ingredient Flucloxacillin false Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) Has active ingredient Flucloxacillin sodium false Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) Has active ingredient Substance with antibacterial mechanism of action false Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) Has active ingredient Flucloxacillin sodium false Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) Has manufactured dose form Oral dose form false Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) Is a Magnapen true Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ampicillin true Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Flucloxacillin true Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) Has specific active ingredient Ampicillin trihydrate true Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) Has specific active ingredient Flucloxacillin sodium true Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) Has manufactured dose form Conventional release oral capsule true Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) Has basis of strength substance Ampicillin true Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) Has basis of strength substance Flucloxacillin true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) 20 capsule Is pack of False Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) 100 capsule 10 x 10 capsules Is pack of False Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) 100 capsule 10 x 10 capsules Has AMP True Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) 20 capsule Has AMP True Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start